Antisocial personality disorder — structured clinical viva

Diagnosis first. Confirm DSM ASPD: age ≥18, ≥3/7 behavioural criteria since 15, conduct disorder onset before 15, not solely during schizophrenia/bipolar episodes. Collateral and records matter because minimisation is common.[1]

Psychopath? Do not equate labels. Psychopathy is a research/forensic construct with interpersonal-affective (Factor 1) and lifestyle-antisocial (Factor 2) domains; PCL instruments are specialised, not a casual clinic insult. He may or may not be high on psychopathic traits — that is a separate dimensional question with risk and engagement implications, not a synonym for ASPD.[2][3]

Untreatable? Wrong framing. Cochrane evidence for ASPD-specific psychological therapies is limited; no drug treats ASPD as a whole. That is not permission for nihilism. Treat alcohol dependence aggressively, formulate violence risk with static/dynamic/protective factors (tools modestly predictive only), set boundaries, multi-agency plan with probation, and offer structured psychological engagement. MBT-informed work has emerging RCT evidence in ASPD populations — cite as structured option, not cure-all.[4][5][6][7][8]

Antipsychotic for personality? No — not as disease-modifying ASPD treatment. Consider only time-limited, target-symptom specialist use (e.g. comorbid psychosis or carefully defined severe aggression after non-drug strategies) with monitoring and stop date. Answer the consultant with Cochrane pharmacological humility.[6]